NCT05256095

Brief Summary

This study examines a cognitive therapy for autistic children, Thinking in Speech. Thinking in Speech helps children with autism independently cope with everyday events that cause stress, by developing their ability to use "inner speech".

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 12, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 15, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 25, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2022

Completed
Last Updated

October 3, 2024

Status Verified

October 1, 2024

Enrollment Period

1.2 years

First QC Date

February 15, 2022

Last Update Submit

October 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Emotion Dysregulation Inventory scores to Post-Intervention

    This measure assesses participants' emotion dysregulation via a 30-item measure. 24 items measure reactivity and 6 items measure dysphoria. A raw score is created by summing the items for each subscale, and ranges from 0-96. Higher scores indicate greater emotion dysregulation and lower scores indicate less emotional dysregulation. Participants will be assessed using this measure at baseline and after therapy is completed.

    Up to 20 weeks

Secondary Outcomes (3)

  • Number of Thinking in Speech therapy sessions attended among all participants

    Up to 20 weeks

  • Change from Baseline in Patient-Reported Outcomes Measurement Information System - Anger Measure to Post-Intervention

    Up to 20 weeks

  • Change from Baseline in Patient-Reported Outcomes Measurement Information System - Anxiety Short Form to Post-Intervention

    Up to 20 weeks

Study Arms (2)

Immediate Assignment to Intervention Group

EXPERIMENTAL

This group will begin to receive the intervention immediately upon entering the study. Thinking in Speech is a novel cognitive therapy that helps children with autism independently cope with everyday events that cause stress, by developing their ability to use inner speech. Participants will complete two sessions per week for eight week, for a total of sixteen sessions. Sessions will be conducted by speech-language pathologists who are trained in Thinking in Speech. Sessions will be conducted via a secure Zoom platform.

Behavioral: Thinking in Speech

Waitlist Assignment to Intervention Group

EXPERIMENTAL

The Waitlist group will begin to receive the intervention 10 weeks after entering the study. Thinking in Speech is a novel cognitive therapy that helps children with autism independently cope with everyday events that cause stress, by developing their ability to use inner speech. Participants will complete two sessions per week for eight week, for a total of sixteen sessions. Sessions will be conducted by speech-language pathologists who are trained in Thinking in Speech. Sessions will be conducted via a secure Zoom platform.

Behavioral: Thinking in Speech

Interventions

Thinking in Speech is a therapy to help children with autism learn to cope with daily stressors and improve their communication.

Immediate Assignment to Intervention GroupWaitlist Assignment to Intervention Group

Eligibility Criteria

Age7 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Verbal language ability as reported by the caregiver
  • Ages 7-11
  • Prior autism or related neurocognitive diagnosis
  • Child proficient in English
  • Caregiver proficient in English
  • Residing in Pennsylvania
  • Access to internet at home

You may not qualify if:

  • History of major child mental illness (e.g., bipolar, schizophrenia, psychosis)
  • Child visual and/or hearing impairment that interferes with his/her ability to participate in therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Autism Spectrum DisorderSpeech

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersVerbal BehaviorCommunicationBehavior

Study Officials

  • Barbara Baumann, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: All participants will receive the Thinking in Speech Therapy
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Instructor in Psychiatry

Study Record Dates

First Submitted

February 15, 2022

First Posted

February 25, 2022

Study Start

May 12, 2021

Primary Completion

August 10, 2022

Study Completion

August 10, 2022

Last Updated

October 3, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations